ライフサイエンスコーパス: willingness

1 CI 1.39-3.16) was associated with increased willingness.

2 minal withdrawal and the factors influencing willingness.

3 ween $5 000 and $50 000 had little impact on willingness.

4 gression models to assess correlates of PrEP willingness.

5 about IRD understanding, self-efficacy, and willingness.

6 cost-infliction ability, and cost-infliction willingness.

7 ould be willing to participate in a biobank; willingness and attitudes did not differ between respond

8 To measure the extent and willingness and to encourage and guide participants to c

9 ity to self-initiate actions, as well as the willingness and/or vigor with which these responses are

10 y was to explore PrEP awareness, uptake, and willingness, as well as associated barriers and facilita

11 R JMD for the more clinically relevant tasks-willingness (at least 50% of the time) to swap devices o

12 nefit-generation ability, benefit-generation willingness, cost-infliction ability, and cost-inflictio

13 The attractiveness of these models and the willingness for countries to test them are currently bei

14 entified HHC-level variables associated with willingness may inform education and counseling efforts

15 rocedures conducted over a decade ago on the willingness of a patients to undergo the surgery again.

16 for self-exams, and (3) the feasibility and willingness of clinicians and their patients to use the

17 and the need for HIV-positive donors and the willingness of HIV-positive recipients to accept organs

18 sm mimics ubiquitous situations in which the willingness of individuals to adopt a new product depend

19 population health benefits do not depend on willingness of individuals to make long-lasting difficul

20 There is limited evidence on the willingness of MDR-TB HHCs to take MDR-TB preventive the

21 was measured after a procedure affected the willingness of mice to interact with a handler.

22 ry grows; however, little is known about the willingness of patients to travel for care.

23 odontal surgery cited in the literature, and willingness of practitioners to adopt guidelines, the es

24 Our study evaluated the willingness of retired surgeons to mentor newly trained

25 the more-affected arm, it also increased the willingness of the patients to assign force to that arm.

26 ffected side reduced noise and increased the willingness of the patients to exert effort.

27 -care speculum exam, (2) the feasibility and willingness of women to use the Callascope for self-exam

28 There is forward motion and a willingness on many sides to understand and address the

29 These data suggest a substantial willingness on the part of patients with heart failure w

30 ing women, necessarily requires a widespread willingness (particularly by those in the majority) to a

31 ssibly random decisions, displaying almost a willingness to 'walk away', whereas those with obsessive

32 Willingness to accept an IRD kidney (secondary outcome)

33 Willingness to accept an IRD kidney did not differ betwe

34 tation waiting list was updated to reflect a willingness to accept either an HCV-positive or HCV-nega

35 orrelated in the post-KAS cohort with center willingness to accept hard-to-place kidneys (r=0.55, P<0

36 Willingness to accept HCV-viremic hearts for transplanta

37 to decide about (38% vs 70%, P < 0.001), and willingness to accept IRD kidneys (25% vs 72%, P < 0.001

38 MC significantly increased and the reported willingness to accept MC increased to 52.6% (255/485), 6

39 effective model for improving participants' willingness to accept MC, while Model A was most success

40 heart failure symptoms influences patients' willingness to accept risks associated with mitral valve

41 with a political leader can fuel partisans' willingness to actively participate in political violenc

42 s the need for flexibility in thinking and a willingness to adopt ideas from a wide diversity of subd

43 luence of personal preference on physicians' willingness to adopt the 60-s/bp images in clinical prac

44 This study aimed to assess women's willingness to alter mammogram frequency based on their

45 smoking 10 or more cigarettes per day, and a willingness to attempt smoking cessation.

46 ase is not due to an increase in the general willingness to bear risks or to altruistically help othe

47 red managing Ebola patients, affecting their willingness to care for them.

48 ith polarization and, additionally, with the willingness to characterize supporters of the opposing c

49 by the donation) increased the participants' willingness to commit to organ donation themselves, dona

50 rmth, and any other cues of one's ability or willingness to confer benefits on partners.

51 The aim of this study was to compare willingness to continue treatment with esomeprazole on-d

52 In terms of willingness to continue treatment, on-demand treatment w

53 tives that would reduce their motivation and willingness to continue.

54 roup types are conditional cooperators whose willingness to contribute is stimulated by generous grou

55 ive for recipients did not undermine donors' willingness to contribute to the program.

56 especially among subjects with low baseline willingness to contribute.

57 utbred mice and rats, familiarity determined willingness to cooccupy the tube, with siblings and/or c

58 udes toward police, including legitimacy and willingness to cooperate.

59 AVP increases humans' willingness to cooperate.

60 h that food deprivation increases the worm's willingness to cross the dangerous barrier by suppressin

61 Information was collected on willingness to donate a kidney and the potential influen

62 online session or control and measured their willingness to donate a portion of their payment for par

63 ey donation-related financial burden affects willingness to donate and the experience of donation, ye

64 orm which had a significant association with willingness to donate cornea after death (p < 0.05, (x)(

65 In turn, these views predicted a decreased willingness to donate either their own or their family m

66 is study aimed to determine the magnitude of willingness to donate eyes and its associated factors, w

67 tion service is affected by various factors, willingness to donate eyes is an essential indicator of

68 The magnitude of willingness to donate eyes was moderate and positively a

69 Willingness to donate one's DNA and health data for rese

70 gst the study population but a good level of willingness to donate organs (67%).

71 With respondents grouped by willingness to donate, we found that 689 (68%) would don

72 compared to other health data and increased willingness to donate.

73 ur research is also a consumer survey on the willingness to eat insects fed with Styrofoam (EPS 80).

74 th encouragement for repeated attempts and a willingness to embrace failure.

75 ficantly associated with increased caregiver willingness to endorse palliative care and withdraw life

76 racism, sexism, welfare opposition, and even willingness to enforce group hegemony violently by parti

77 study was threefold: (i) understand people's willingness to engage in either punishment of the perpet

78 ntrol is important in understanding people's willingness to engage in future-oriented behavior.

79 on and aggression causally increases humans' willingness to engage in risky, mutually beneficial coop

80 ound six themes; 1) timing and tailoring, 2) willingness to engage, 3) roles and responsibilities of

81 prevalence of disorders showing a diminished willingness to exert effort (e.g., depression).

82 aracteristics of baseline working memory and willingness to exert effort for reward moderated the eff

83 We found that substantial variability in willingness to exert effort for reward was not associate

84 ng of clinical disorders that show a reduced willingness to exert effort in the pursuit of reward.SIG

85 and instrumental behavior, and a diminished willingness to exert effort is a characteristic feature

86 or cost shapes human behavior, and a reduced willingness to exert effort is a characteristic of many

87 d-Amphetamine increased willingness to exert effort, particularly at low to inte

88 ic neurons underlies incentive motivation, a willingness to exert high levels of effort to obtain rei

89 gher doses of the D(1) agonist increased the willingness to exert physical effort for reward as well

90 We found that methylphenidate boosts willingness to expend cognitive effort by altering the b

91 isms underlying state and trait variation in willingness to expend cognitive effort.SIGNIFICANCE STAT

92 a subset of negative symptoms with a reduced willingness to expend costly effort, often observed in p

93 amine (DA) that is associated with a reduced willingness to expend effort for reward.

94 omes and aversive prediction errors; reduced willingness to expend effort for rewards; and psychomoto

95 Willingness to expend effort was greater for participant

96 Tail handled mice showed little willingness to explore and investigate test stimuli, lea

97 nces, their reasons for attending, and their willingness to explore new approaches that would reduce

98 situation and exploration is an individual's willingness to explore novel situations.

99 turn can motivate self-sacrifice, including willingness to fight and die for the group.

100 the factors affecting patients' ability and willingness to follow pressure ulcer prevention interven

101 cated the notion of hyperaltruism (i.e., the willingness to forego reward to spare others from harm),

102 n during planning is predictive of someone's willingness to forgo immediate small rewards in favor of

103 humanizing language increased participants' willingness to harm strangers for money, but not partici

104 m strangers for money, but not participants' willingness to harm strangers for their immoral behavior

105 perceived norms in three domains of stigma: willingness to have the woman marry into their family, b

106 ative emotions, which can reduce empathy and willingness to help.

107 re assessed for behavioural risk factors and willingness to initiate PrEP.

108 ntention, and not to influence a recipient's willingness to interact sexually.

109 in standard behavioural tests and increased willingness to interact with a handler within hours afte

110 traint, tunnel handled mice showed increased willingness to interact with a handler, and reduced anxi

111 iated the relationship between condition and willingness to interact with target.

112 Willingness to lay down one's life for a group of non-ki

113 ng of disease etiology have been driven by a willingness to learn about and incorporate into epidemio

114 Personal relationships and willingness to learn from each other's successes and fai

115 ned a commitment strength, w, defining their willingness to lose (in waning), gain (for increasing) o

116 ly hedonic or affective reasons, such as the willingness to maintain one's moral self-image, but also

117 A female fly signals her willingness to mate by opening her vaginal plates, allow

118 Attitudes toward risk, informed consent, and willingness to participate in 3 research scenarios invol

119 We assessed willingness to participate in a biobank using different

120 patients understand this agreement and their willingness to participate in additional treatment is un

121 utely ill, CD4 count not <200 cells/mm3) and willingness to participate in an AC.

122 ionship with the patient, (2) demonstrates a willingness to participate in decision-making, (3) artic

123 Willingness to participate was associated with self-iden

124 An increased willingness to participate was reported among the majori

125 n criteria were age of 18 years or older and willingness to participate.

126 nd donor travel were associated with reduced willingness to participate.

127 benefit in favour of second-generation TKI (willingness to pay $200 000 per QALY, 66% of patients ac

128 consultants with no formal allergy training [Willingness to pay (WTP) estimates for nurse specialist

129 Main outcome measures Preference and willingness to pay estimates for each of the specified a

130 he effects of both mindsets on participants' willingness to pay for familiar food items while being s

131 ith LAIV, however, was sensitive both to the willingness to pay for health benefits and to assumption

132 The higher societal willingness to pay for one extra pain-free patient, the

133 we present a simple model for assessing the willingness to pay for reductions in the risk associated

134 ncy between conservation needs and society's willingness to pay for them grows, conservation will hav

135 about spectacles, barriers for their use and willingness to pay for them were collected.

136 We found that willingness to pay increased for food items only after s

137 h each strategy would be cost-effective at a willingness to pay of $100 000 per quality-adjusted life

138 edicted 0% chance of cost effectiveness at a willingness to pay of $100,000 per QALY gained.

139 care Xpert being cost-effective was 90% at a willingness to pay of $3820 per treatment completion.

140 of generic imatinib of $2100 per year and a willingness to pay of $50 000 per QALY, the annual price

141 Assuming a willingness to pay of $50 000 per QALY, trabeculectomy a

142 At a conservative willingness to pay of $50 000/QALY, there is room to exp

143 In probabilistic analysis, at a willingness to pay of $50000, antimicrobial lock solutio

144 ore cost-effective than eye drops first at a willingness to pay of pound 20 000 per quality-adjusted

145 were more cost-effective, mainly for higher willingness to pay threshold (US $100 000 and US $150 00

146 ed from a health system perspective, using a willingness to pay threshold equivalent to 1 month's wag

147 screening strategy was determined based on a willingness to pay threshold of $100,000 per life-year g

148 gy with the best cost-benefit ratio, up to a willingness to pay threshold of $50,000-100,000 per case

149 chance of HAP being cost-effective, given a willingness to pay threshold of Intl$16,060-equivalent t

150 ared with usual care being at least 95% at a willingness to pay threshold of pound 20,000 to 30,000 p

151 The intervention was cost-effective at willingness to pay thresholds in excess of pound 8540.

152 n both cost and effect using a wide range of willingness to pay thresholds, we found less than 3% pro

153 , and an estimate from the literature on the willingness to pay to avoid asthma symptoms, we show tha

154 eneric F/TDF ($8300 per year) and a societal willingness to pay up to $100 000 per QALY, the maximum

155 Willingness to pay was affected by the participant's cur

156 ntary risk-based testing under a pound20,000 willingness to pay with current treatments but likely to

157 nt and cost per donor is less than society's willingness to pay, donor registry promotion offers posi

158 Using conservative estimates for willingness to pay, the quality-adjusted life-year loss

159 dent of identification with him, study 5); a willingness to persecute immigrants (study 6); and a wil

160 effects, this fusion with Trump predicted a willingness to persecute Iranians (independent of identi

161 ess to persecute immigrants (study 6); and a willingness to personally protect the US border from an

162 their perceived QoL, sense of identity, and willingness to proceed with FT in the context of 3 diffe

163 r "never" ask patients who smoke about their willingness to quit smoking, and 249 (85%) "seldom" or "

164 f do not ask, or seldom ask, about patients' willingness to quit smoking, and most do not discuss smo

165 However, no study has ever explored the willingness to receive palliative care or terminal withd

166 trustee's behaviour may change the trustee's willingness to reciprocate, causing either a decrease du

167 o inequality decreases affluent individuals' willingness to redistribute.

168 lications, outcomes of procedures, patients' willingness to repeat the procedure, and the amount of t

169 s or a mutation in TMEM43; and the patient's willingness to restrict exercise and to eliminate partic

170 (VAS) and showed a positive correlation with willingness to retreat (P < 0.01).

171 ASs) were used to assess self-reported pain, willingness to retreat and satisfaction.

172 Willingness to retreat was negatively affected by mandib

173 Willingness to retreatment was 84.6% and it was negative

174 Participants were asked about their willingness to seek regionalized care in a hypothetical

175 CI 0.41-0.86) were associated with decreased willingness to seek regionalized care, while high income

176 and lower income are associated with reduced willingness to seek regionalized care.

177 Willingness to share has been critically important for o

178 ation cases in the media may affect people's willingness to sign organ donation commitment cards, don

179 The economic model focuses on society's willingness to substitute consumption across time and ac

180 ntries, enrollees were interviewed to assess willingness to take a hypothetical, newly developed MDR

181 sexual partner in the last 12 months, stated willingness to take an STI test, and had access to the i

182 HHC willingness to take hypothetical MDR TPT was high (79%)

183 To identify factors associated with willingness to take MDR TPT, a marginal logistic model w

184 There was no difference in willingness to take PrEP between black and white MSM.

185 Willingness to take PrEP was low, at 56 (55%) of 102, am

186 timating equations to explore differences in willingness to take PrEP, PrEP use, and indications for

187 follows: 1. At-risk MSM; 2. Awareness of and willingness to take PrEP; 3. Access to healthcare; 4. Re

188 cted sequential effects, including increased willingness to take risks following risky wins, and spat

189 dissociated from participants' impulsivity, willingness to take risks, and mood.

190 Humans vary substantially in their willingness to take risks.

191 loss as worse than death and showed minimal willingness to trade a reduction in this outcome with an

192 Willingness to trade years of graft survival to minimize

193 ty to a major center was not associated with willingness to travel (OR 0.92, 95% CI 0.67-1.22).

194 When asked, 84.7% of survivors indicated willingness to undergo mechanical ventilation again.

195 erform daily activities, and 84.7% indicated willingness to undergo mechanical ventilation again.

196 355 (97.8%) patients indicated willingness to undergo repeat SRFA with little to no fea

197 ion criteria were 18-50 years of age, use or willingness to use contraception to avoid pregnancy, and

198 Many countries show a growing willingness to use militaries in support of global healt

199 en who have sex with men (MSM), we report on willingness to use PrEP and PrEP utilization.

200 ite preference for tofacitinib, and definite willingness to use tofacitinib again on the IBD PRTI at

201 accine propensity, which relates a change in willingness to vaccinate with a change in perceived risk

202 creased fusion with Trump and, subsequently, willingness to violently challenge election results.

203 ion with Donald Trump predicted Republicans' willingness to violently persecute Muslims (over and abo

204 evels of civic engagement, as shown by their willingness to vote, sign petitions and donate to charit

205 Changing dopamine immediately altered willingness to work and reinforced preceding action choi

206 food-related anticipatory activity task, (2) willingness to work for reward using a progressive ratio

207 sgACC/25 over-activation also reduces the willingness to work for reward.

208 s to identify one type of support for change-willingness to work in solidarity- that is positively as

209 the model reproduces drug-induced changes of willingness to work, as observed in classical experiment

210 ted state on both scanning days) performed a willingness-to-eat task in a separate fMRI measurement.

211 Similarly, for plastic sanitary platforms, willingness-to-pay (WTP) dropped from almost 60% at a pr

212 ategy compared with a standard strategy at a willingness-to-pay (WTP) threshold of $50 000 per QALY g

213 Treatments with an ICER below the standard willingness-to-pay (WTP) threshold of $50,000/QALY were

214 strategy) across a range of country-specific willingness-to-pay (WTP) values, estimate and investigat

215 level of financial incentives will depend on willingness-to-pay for health and other modeling assumpt

216 ayment by as much as 18% to 44% depending on willingness-to-pay for health.

217 ttractive at current benchmarks for societal willingness-to-pay in the United States.

218 These ICERs are in line with willingness-to-pay levels of one times the country's gro

219 payer perspective, a lifetime horizon, and a willingness-to-pay of $150 000 per quality-adjusted life

220 ce in population-level net monetary benefit (willingness-to-pay of $50 000 to $150 000/quality-adjust

221 bsidies needed to bridge the gap between the willingness-to-pay of low-income households and actual m

222 cost-effective strategy (99.9% preferred at willingness-to-pay of US$50000) and on average would sav

223 n if reduced mortality risks are valued with willingness-to-pay or as income from increased life expe

224 ctive intervention at expected thresholds of willingness-to-pay per additional pelvic infection avoid

225 At a threshold willingness-to-pay ratio of pound 20,000 ($28,433 in U.S

226 model iterations favored laser ablation at a willingness-to-pay ratio of pound 20,000 ($28,433) per Q

227 lties became the optimum strategy at the NHS willingness-to-pay threshold ( pound30,000/QALY).

228 n up to age 20 years remained below Norway's willingness-to-pay threshold (approximately $83 000/qual

229 robust, with 93.5% being below an arbitrary willingness-to-pay threshold (WTP) of $20 000 per fungal

230 At a pound30,000/QALY willingness-to-pay threshold and current prevalence, onl

231 of being cost effective at the $100,000/QALY willingness-to-pay threshold and never going below $450,

232 $51,597 per QALY gained, which is within the willingness-to-pay threshold for Korea of $56,000/QALY g

233 -effectiveness ratio remained lower than the willingness-to-pay threshold in 74% of iterations in the

234 ts can be interpreted as cost-effective at a willingness-to-pay threshold in Belgium of euro35000 (US

235 ts can be interpreted as cost-effective at a willingness-to-pay threshold in Belgium of euro35000 (US

236 The ICER is below the willingness-to-pay threshold in the Netherlands, indicat

237 vers is excluded, (ii) 58%-84% higher if the willingness-to-pay threshold is increased to three times

238 listic sensitivity analysis showed that at a willingness-to-pay threshold of $100 000 per QALY gained

239 At a willingness-to-pay threshold of $100 000 per QALY gained

240 of the health care sector perspective and a willingness-to-pay threshold of $100 000 per QALY showed

241 At a willingness-to-pay threshold of $100 000 per QALY, sofos

242 ad a 99.5% chance of cost-effectiveness at a willingness-to-pay threshold of $100 000 per QALY.

243 A willingness-to-pay threshold of $100 000 per quality-adj

244 ction treatment (ICER $95 337 per QALY) at a willingness-to-pay threshold of $100 000.

245 ng in an ICER of $31 751 per QALY, below the willingness-to-pay threshold of $100 000/QALY.

246 est INMBs ($759 and $741, respectively, at a willingness-to-pay threshold of $100,000 per QALY gained

247 tus quo; >99.9% of iterations fell below the willingness-to-pay threshold of $100,000 per QALY.

248 suppression coverage was cost-effective at a willingness-to-pay threshold of $100,000, $50,000, and $

249 tion was cost effective 76% of the time at a willingness-to-pay threshold of $100,000/QALY.

250 of $69,350, it is not cost-effective using a willingness-to-pay threshold of $100,000/quality-adjuste

251 A willingness-to-pay threshold of $100000 per QALY was use

252 ibrutinib therapy to be cost-effective at a willingness-to-pay threshold of $150 000 per QALY.

253 An upper willingness-to-pay threshold of $150 000 per quality-adj

254 ectively) relative to status quo and at a US willingness-to-pay threshold of $150 000/QALY saved.

255 Our analysis established that assuming a willingness-to-pay threshold of $163,371/life year (qual

256 38% of iterations and was within a societal willingness-to-pay threshold of $50 000 in 98% of models

257 At a willingness-to-pay threshold of $50 000 per quality-adju

258 al cost-effectiveness ratios (ICERs) under a willingness-to-pay threshold of $50 000/QALY gained.

259 analyses, the ICURs were within the societal willingness-to-pay threshold of $50 000/QALY in approxim

260 would be cost-effective (51 to 79% below the willingness-to-pay threshold of $50,000 per QALY and 76

261 olds that affect optimal management, using a willingness-to-pay threshold of $50,000/QALY.

262 At the willingness-to-pay threshold of 100 000 Swiss Francs (CH

263 ogressive keratoconus is cost effective at a willingness-to-pay threshold of 3 times the current gros

264 US$22.74 (15.49-34.45) with HPV-ADVISE, at a willingness-to-pay threshold of AUS$30 000 per quality-a

265 ast tomosynthesis is not cost-effective at a willingness-to-pay threshold of euro 20 000 per life-yea

266 reening plus surveillance exceeded the Dutch willingness-to-pay threshold of euro36 602 per life-year

267 cremental cost-effectiveness ratio (ICER) at willingness-to-pay threshold of GBPpound 20,000.

268 nalysis from the societal perspective with a willingness-to-pay threshold of one times the gross dome

269 At a willingness-to-pay threshold of pound 20 000 per quality

270 T was cost-effective in 100% of samples at a willingness-to-pay threshold of US $100 000 in the base-

271 We used a willingness-to-pay threshold of US$1950, the 2017 Indian

272 We adapt the health economics willingness-to-pay threshold to a solid organ transplant

273 parents and caregivers, (iii) increasing the willingness-to-pay threshold to three times GDPpc, (iv)

274 ar, with 98% likelihood of meeting a $100000 willingness-to-pay threshold).

275 cost effective in England at the current NHS willingness-to-pay threshold, and our findings informed

276 ely to be cost-effective under a pound20,000 willingness-to-pay threshold.

277 ERs) were compared to a $100 000/QALY gained willingness-to-pay threshold.

278 ncremental cost-effectiveness ratio, and the willingness-to-pay threshold.Finally, the advantages and

279 treatment-naive noncirrhotic patients exceed willingness-to-pay thresholds commonly cited in the Unit

280 tuzumab) were more cost-effective across all willingness-to-pay thresholds in the low-risk group.

281 andard care in nearly all 10 000 samples, at willingness-to-pay thresholds of $50 000 or more per QAL

282 Willingness-to-pay thresholds of euro 20 000 ($22 000) a

283 ive in 48.4% and 57.4% of the simulations at willingness-to-pay thresholds of GBPpound 20,000 (US$26,

284 There was a probability range of 47-87% for willingness-to-pay thresholds of pound 0-1000 for a unit

285 l Institute for Health and Care Excellence's willingness-to-pay thresholds of pound 20 000 and pound

286 onged life and did so at levels below common willingness-to-pay thresholds per QALY, regardless of wh

287 cceptability curves were plotted for various willingness-to-pay thresholds to address uncertainty.

288 planes and acceptability curves for various willingness-to-pay thresholds.

289 cost-effective under either of the societal willingness-to-pay thresholds.

290 virus mortality estimates and more stringent willingness-to-pay thresholds.

291 ective, with 95% CIs far below the strictest willingness-to-pay thresholds.

292 uently cost-effective across a wide range of willingness-to-pay thresholds.

293 st-effectiveness by considering two societal willingness-to-pay thresholds: $50 000 per quality-adjus

294 n of cost-effectiveness with a wide range of willingness-to-pay values for a unit improvement in the

295 al of 2381 low-income households to estimate willingness-to-pay.

296 s to ELF and transient elastography or lower willingness-to-pay.

297 nsplant setting by coining a new metric: the willingness-to-transplant (WTT) threshold.

298 Willingness was also increased with an advantage to the

299 Increased willingness was significantly associated with current em

300 and data sharing models, hypothesizing that willingness would be higher under more restrictive scena